Correction: Neurokinin-1 receptor promotes non-small cell lung cancer progression through transactivation of EGFR
Xiao-Wei Zhang, Lin Li, Wen-Qian Hu, Ming-Ning Hu, Yan Tao, Hui Hu, Xiao-Kang Miao, Wen-Le Yang, Qiong Zhu, Ling-Yun Mou
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCancer, Stress, Anesthesia, and Immune Response · Neuropeptides and Animal Physiology · HER2/EGFR in Cancer Research
Correction to: Cell Death and Disease 10.1038/s41419-021-04485-y, published online 10 January 2022
We discovered that the NK1R Western-blot panel in Fig. 5E was inadvertently duplicated with Vimentin in Fig. 3E during manual layout. Our article contains 193 individual Western-blot panels distributed over 21 composite figures; the error arose while rearranging these panels in PowerPoint.
Amended Fig 5
Original data of Fig.3
Original data of Fig.5
The original article has been corrected.